These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial. Beck RW; Gal RL Arch Ophthalmol; 2008 Jul; 126(7):994-5. PubMed ID: 18625951 [No Abstract] [Full Text] [Related]
8. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group. Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788 [TBL] [Abstract][Full Text] [Related]
9. The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results. Volpe NJ Arch Ophthalmol; 2008 Jul; 126(7):996-9. PubMed ID: 18625952 [No Abstract] [Full Text] [Related]
11. Should Oral Corticosteroids Be Used to Treat Demyelinating Optic Neuritis? Morrow MJ; Ko MW J Neuroophthalmol; 2017 Dec; 37(4):444-450. PubMed ID: 28857910 [No Abstract] [Full Text] [Related]
12. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Optic Neuritis Study Group Ophthalmology; 2008 Jun; 115(6):1079-1082.e5. PubMed ID: 17976727 [TBL] [Abstract][Full Text] [Related]
13. Acute ganglion cell loss during rapid visual recovery in optic neuritis. Fukuchi M; Kishi S; Li D; Akiyama H Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2355-2360. PubMed ID: 27299339 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial. Schinzel J; Schwarzlose L; Dietze H; Bartusch K; Weiss S; Ohlraun S; Paul F; Dörr J Trials; 2012 Jun; 13():94. PubMed ID: 22742888 [TBL] [Abstract][Full Text] [Related]
15. The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial. Beck RW; Cleary PA; Backlund JC; Ophthalmology; 2020 Apr; 127(4S):S174-S181. PubMed ID: 32200819 [TBL] [Abstract][Full Text] [Related]
16. Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial. Moss HE; Gao W; Balcer LJ; Joslin CE JAMA Ophthalmol; 2014 Apr; 132(4):421-7. PubMed ID: 24557028 [TBL] [Abstract][Full Text] [Related]
17. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Beck RW; Cleary PA; Backlund JC Ophthalmology; 1994 Nov; 101(11):1771-8. PubMed ID: 7800355 [TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis, the great masquerader: an atypical ocular presentation. Erneston AG J Am Optom Assoc; 1997 Dec; 68(12):757-62. PubMed ID: 9635381 [TBL] [Abstract][Full Text] [Related]
19. Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial. Morrow SA; Fraser JA; Day C; Bowman D; Rosehart H; Kremenchutzky M; Nicolle M JAMA Neurol; 2018 Jun; 75(6):690-696. PubMed ID: 29507942 [TBL] [Abstract][Full Text] [Related]